Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Flares in Patients with Rheumatoid Arthritis after Total Hip and Total Knee Arthroplasty: Rates, Characteristics, and Risk Factors.

Goodman SM, Bykerk VP, DiCarlo E, Cummings RW, Donlin LT, Orange DE, Hoang A, Mirza S, McNamara M, Andersen K, Bartlett SJ, Szymonifka J, Figgie MP.

J Rheumatol. 2018 May;45(5):604-611. doi: 10.3899/jrheum.170366. Epub 2018 Mar 15.

PMID:
29545451
2.

Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation.

Stephenson W, Donlin LT, Butler A, Rozo C, Bracken B, Rashidfarrokhi A, Goodman SM, Ivashkiv LB, Bykerk VP, Orange DE, Darnell RB, Swerdlow HP, Satija R.

Nat Commun. 2018 Feb 23;9(1):791. doi: 10.1038/s41467-017-02659-x.

3.

Identification of Three Rheumatoid Arthritis Disease Subtypes by Machine Learning Integration of Synovial Histologic Features and RNA Sequencing Data.

Orange DE, Agius P, DiCarlo EF, Robine N, Geiger H, Szymonifka J, McNamara M, Cummings R, Andersen KM, Mirza S, Figgie M, Ivashkiv LB, Pernis AB, Jiang CS, Frank MO, Darnell RB, Lingampali N, Robinson WH, Gravallese E; Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network, Bykerk VP, Goodman SM, Donlin LT.

Arthritis Rheumatol. 2018 May;70(5):690-701. doi: 10.1002/art.40428. Epub 2018 Apr 2.

PMID:
29468833
4.

T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy.

Blachère NE, Orange DE, Gantman EC, Santomasso BD, Couture GC, Ramirez-Montagut T, Fak J, O'Donovan KJ, Ru Z, Parveen S, Frank MO, Moore MJ, Darnell RB.

JCI Insight. 2017 Nov 2;2(21). pii: 96173. doi: 10.1172/jci.insight.96173. [Epub ahead of print]

5.

High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.

Blachère NE, Parveen S, Frank MO, Dill BD, Molina H, Orange DE.

Arthritis Rheumatol. 2017 May;69(5):986-995. doi: 10.1002/art.40035.

6.

Inflammatory but not apoptotic death of granulocytes citrullinates fibrinogen.

Blachère NE, Parveen S, Fak J, Frank MO, Orange DE.

Arthritis Res Ther. 2015 Dec 17;17:369. doi: 10.1186/s13075-015-0890-0.

7.

Dendritic cell vaccines containing lymphocytes produce improved immunogenicity in patients with cancer.

Frank MO, Kaufman J, Parveen S, Blachère NE, Orange DE, Darnell RB.

J Transl Med. 2014 Dec 5;12:338. doi: 10.1186/s12967-014-0338-3.

8.

T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.

Blachère NE, Orange DE, Santomasso BD, Doerner J, Foo PK, Herre M, Fak J, Monette S, Gantman EC, Frank MO, Darnell RB.

Eur J Immunol. 2014 Nov;44(11):3240-51. doi: 10.1002/eji.201444624.

9.

Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo.

Orange DE, Blachere NE, Fak J, Parveen S, Frank MO, Herre M, Tian S, Monette S, Darnell RB.

Elife. 2013 Feb 5;2:e00105. doi: 10.7554/eLife.00105.

10.

Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy.

Orange DE, Jegathesan M, Blachère NE, Frank MO, Scher HI, Albert ML, Darnell RB.

Prostate Cancer Prostatic Dis. 2004;7(1):63-72.

PMID:
14999241

Supplemental Content

Loading ...
Support Center